id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1976-N-0520-0011,FDA,FDA-1976-N-0520,Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of Three New Drug Applications for Estrogen-Androgen Combination Drugs,Notice,NWL-Notice of Withdrawl,1998-11-04T05:00:00Z,1998,11,,,2018-08-02T16:31:49Z,,0,0,090000648053be5b
FDA-1976-N-0520-0010,FDA,FDA-1976-N-0520,"Eli Lilly & Co. and Bristol-Myers Squibb Co.; Withdrawal of Approval of
Three New Drug Applications for Estrogen-Androgen Combination Drugs",Notice,Withdrawal,1998-11-04T05:00:00Z,1998,11,,,2018-08-02T16:31:12Z,98-29049,0,0,090000648053be5a